Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Depaul, Marc A ^a   Palmer, Marc ^b   Lang, Bradley T ^a,b   Cutrone, Rochelle ^b   Tran, Amanda P ^a   Madalena, Kathryn M ^a   Bogaerts, Annelies ^c   Hamilton, Jason A ^b   Deans, Robert J ^b   Mays, Robert W ^b   Busch, Sarah A ^b   Silver, Jerry ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATHERSYS INC   (United States)

^c ReGenesys   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; ADULT STEM CELL; ANIMAL; AXON; COMPLICATION; CONVALESCENCE; CYTOLOGY; DNA MICROARRAY; FEMALE; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; METABOLISM; MICTURITION; MOTOR ACTIVITY; MULTIPOTENT STEM CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION; TISSUE DISTRIBUTION;

ADULT; ADULT STEM CELLS; ANIMALS; ARGINASE; AXONS; FEMALE; HUMANS; INFLAMMATION; INJECTIONS, INTRAVENOUS; MACROPHAGES; MOTOR ACTIVITY; MULTIPOTENT STEM CELLS; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TISSUE DISTRIBUTION; URINATION;

EID: 84947593284     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16795     Document Type: Article

References (74)

1. Kabatas, S. et al. Neural and anatomical abnormalities of the gastrointestinal system resulting from contusion spinal cord injury. Neuroscience 154, 1627-1638 (2008).
2. Cao, Q. et al. Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp Neurol 191 Suppl 1, S3-S16 (2005).
3. el-Bohy, A. A., Schrimsher, G. W., Reier, P. J., Goshgarian, H. G. Quantitative assessment of respiratory function following contusion injury of the cervical spinal cord. Exp Neurol 150, 143-152 (1998).
4. Herrera, J. J., Haywood-Watson, R. J. L., Grill, R. J. Acute and chronic deficits in the urinary bladder after spinal contusion injury in the adult rat. J Neurotrauma 27, 423-431 (2010).
5. Bradbury, E. J. et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640 (2002).
6. Massey, J. M. et al. Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. Journal of Neuroscience 26, 4406-4414 (2006).
7. Pizzorusso, T. et al. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298, 1248-1251 (2002).
8. Totoiu, M. O., Keirstead, H. S. Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 486, 373-383 (2005).
9. Tator, C. H., Fehlings, M. G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26 (1991).
10. Fitch, M. T., Doller, C., Combs, C. K., Landreth, G. E., Silver, J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. Journal of Neuroscience 19, 8182-8198 (1999).
11. Jones, T. B. Lymphocytes and autoimmunity after spinal cord injury. Exp Neurol 258, 78-90 (2014).
12. Schwab, J. M., Zhang, Y., Kopp, M. A., Brommer, B., Popovich, P. G. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol 258, 121-129 (2014).
13. David, S., Kroner, A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12, 388-399 (2011).
14. Kigerl, K. A. et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. Journal of Neuroscience 29, 13435-13444 (2009).
15. Busch, S. A., Horn, K. P., Silver, D. J., Silver, J. Overcoming macrophage-mediated axonal dieback following CNS injury. Journal of Neuroscience 29, 9967-9976 (2009).
16. Giulian, D., Robertson, C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol. 27, 33-42 (1990).
17. Blight, A. R. Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage. Neuroscience 60, 263-273 (1994).
18. Rapalino, O. et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4, 814-821 (1998).
19. Kotter, M. R., Zhao, C., van Rooijen, N., Franklin, R. J. M. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18, 166-175 (2005).
20. Gadani, S. P., Walsh, J. T., Smirnov, I., Zheng, J., Kipnis, J. The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury. Neuron 85, 703-709 (2015).
21. Kwon, B. K. et al. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma 28, 1545-1588 (2011).
22. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
23. Vaes, B., Van't Hof, W., Deans, R., Pinxteren, J. Application of MultiStem( ) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease. Front Immunol 3, 345 (2012).
24. Roobrouck, V. D. et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 29, 871-882 (2011).
25. Kovacsovics-Bankowski, M. et al. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cell. Immunol. 255, 55-60 (2009).
26. Hess, D. C. et al. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke. Int J Stroke 9, 381-386 (2014).
27. Walker, P. A. et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol 225, 341-352 (2010).
28. Busch, S. A. et al. Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. Journal of Neuroscience 31, 944-953 (2011).
29. Van't Hof, W. et al. Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy 9, 477-487 (2007).
30. Aranguren, X. L. et al. Multipotent adult progenitor cells sustain function of ischemic limbs in mice. J Clin Invest 118, 505-514 (2008).
31. Mora-Lee, S. et al. Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS ONE 7, e43683 (2012).
32. Bedi, S. S. et al. Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. Stem Cells Transl Med 2, 953-960 (2013).
33. Walker, P. A. et al. Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population. J Neuroinflammation 9, 228 (2012).
34. Van Leeuwen, F. W., Salehi, A., Giger, R. J., Holtmaat, A. J. G. D., Verhaagen, J. Neuronal Degeneration and Regeneration: From Basic Mechanisms to Prospects for Therapy. (Elsevier, 1998).
35. Scheff, S. W., Rabchevsky, A. G., Fugaccia, I., Main, J. A., Lumpp, J. E. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J Neurotrauma 20, 179-193 (2003).
36. Robins, S. L., Fehlings, M. G. Models of experimental spinal cord injury: translational relevance and impact. Drug Discovery Today: Disease Models (2008). doi: 10.1016/j.ddmod.2008.07.001.
37. Lang, B. T. et al. Modulation of the proteoglycan receptor PTP promotes recovery after spinal cord injury. Nature 518, 404-408 (2015).
38. Basso, D. M., Beattie, M. S., Bresnahan, J. C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12, 1-21 (1995).
39. Lee, Y.-S. et al. Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury. Journal of Neuroscience 33, 10591-10606 (2013).
40. Alilain, W., Horn, K. P., Hu, H., Dick, T. E., Silver, J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 475, 196-200 (2011).
41. Tuszynski, M. H., Steward, O. Concepts and Methods for the Study of Axonal Regeneration in the CNS. Neuron 74, 777-791 (2012).
42. Ruschel, J. et al. Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injury. Science 348, 347-352 (2015).
43. Koopmans, G. C. et al. The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. J Neurotrauma 22, 214-225 (2005).
44. Popovich, P. G. et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158, 351-365 (1999).
45. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., O'Garra, A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 147, 3815-3822 (1991).
46. Jiang, C., Ting, A. T., Seed, B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86 (1998).
47. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., Glass, C. K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79-82 (1998).
48. Nathan, C. F., Murray, H. W., Wiebe, M. E., Rubin, B. Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158, 670-689 (1983).
49. Ohmori, Y., Hamilton, T. A. Requirement for STAT1 in LPS-induced gene expression in macrophages. J. Leukoc. Biol. 69, 598-604 (2001).
50. Krappmann, D. et al. The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol 24, 6488-6500 (2004).
51. Kroner, A. et al. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 83, 1098-1116 (2014).
52. Buhler, L. A. et al. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis. BMC Neurosci 10, 17 (2009).
53. Blomster, L. V. et al. Mobilisation of the splenic monocyte reservoir and peripheral CXCR1 deficiency adversely affects recovery from spinal cord injury. Exp Neurol 247, 226-240 (2013).
54. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T. Regulatory T cells: how do they suppress immune responses Int. Immunol. 21, 1105-1111 (2009).
55. Roy, D., Steyer, G. J., Gargesha, M., Stone, M. E., Wilson, D. L. 3D cryo-imaging: a very high-resolution view of the whole mouse. Anat Rec (Hoboken) 292, 342-351 (2009).
56. Lucin, K. M., Sanders, V. M., Popovich, P. G. Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J Neurochem 110, 1409-1421 (2009).
57. Zhang, Y. et al. Autonomic Dysreflexia Causes Chronic Immune Suppression after Spinal Cord Injury. Journal of Neuroscience 33, 12970-12981 (2013).
58. Horn, K. P., Busch, S. A., Hawthorne, A. L., van Rooijen, N., Silver, J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. Journal of Neuroscience 28, 9330-9341 (2008).
59. Evans, T. A. et al. High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Exp Neurol 254, 109-120 (2014).
60. Tom, V. J., Steinmetz, M. P., Miller, J. H., Doller, C. M., Silver, J. Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. Journal of Neuroscience 24, 6531-6539 (2004).
61. Shechter, R. et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38, 555-569 (2013).
62. Moalem, G. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5, 49-55 (1999).
63. Raposo, C. et al. CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles. Journal of Neuroscience 34, 10141-10155 (2014).
64. Reading, J. L. et al. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity. J Immunol 190, 4542-4552 (2013).
65. Lakhan, S. E., Kirchgessner, A., Hofer, M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7, 97 (2009).
66. Liesz, A. et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15, 192-199 (2009).
67. Mays, R. W. et al. Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke. J Experimental Stroke Translatinal Medicine 3, 34-46 (2010).
68. English, K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol. Cell Biol. 91, 19-26 (2013).
69. Hodgetts, S. I., Simmons, P. J., Plant, G. W. Human mesenchymal precursor cells (Stro-1+) from spinal cord injury patients improve functional recovery and tissue sparing in an acute spinal cord injury rat model. Cell Transplant 22, 393-412 (2013).
70. Anderson, K. D. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 21, 1371-1383 (2004).
71. Pikov, V., Wrathall, J. R. Coordination of the bladder detrusor and the external urethral sphincter in a rat model of spinal cord injury: effect of injury severity. J Neurosci 21, 559-569 (2001).
72. Hargreaves, K., Dubner, R., Brown, F., Flores, C., Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88 (1988).
73. Cheng, C. L., de Groat, W. C. The role of capsaicin-sensitive afferent fibers in the lower urinary tract dysfunction induced by chronic spinal cord injury in rats. Exp Neurol 187, 445-454 (2004).
74. Jakeman, L. B. Assessment of lesion and tissue sparing volumes following spinal cord injury. Animal Models of Acute Neurological Injuries 2. 417-442 (2012). doi: 10.1007/978-1-61779-782-8-37.